Infinity Pharmaceuticals, Inc.
INFI
INFI was delisted on the 13th of September, 2023.
97 hedge funds and large institutions have $131M invested in Infinity Pharmaceuticals, Inc. in 2021 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 22 increasing their positions, 24 reducing their positions, and 18 closing their positions.
78% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 18
55% more call options, than puts
Call options by funds: $2.06M | Put options by funds: $1.33M
17% more funds holding
Funds holding: 83 → 97 (+14)
4% less capital invested
Capital invested by funds: $136M → $131M (-$5.05M)
8% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 24
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$12.8M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$5.58M |
| 3 |
State Street
Boston,
Massachusetts
|
+$4.22M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.65M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$2.43M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Consonance Capital Management
New York
|
-$8.88M |
| 2 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$5.33M |
| 3 |
TLP
Tri Locum Partners
New York
|
-$3.91M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$2.37M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$1.72M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HF
101
HRT Financial
New York
| – | -$487K | -151,043 | Closed |
|
102
California Public Employees Retirement System
Sacramento,
California
| – | -$285K | -88,100 | Closed |
|
|
HIIFS
103
Harel Insurance Investments & Financial Services
Ramat Gan,
Israel
| – | -$863K | -80,000 | Closed |
|
104
Creative Planning
Overland Park,
Kansas
| – | -$121K | -37,310 | Closed |
|
|
LP
105
LMR Partners
London,
United Kingdom
| – | -$99K | -30,531 | Closed |
|
106
Balyasny Asset Management
Chicago,
Illinois
| – | -$54K | -16,873 | Closed |
|
107
Walleye Capital
New York
| – | -$44 | -13,700 | Closed |
|
|
JG
108
Jefferies Group
New York
| – | -$43.6K | -13,500 | Closed |
|
109
Capstone Investment Advisors
New York
| – | -$41K | -12,709 | Closed |
|
|
APWA
110
Atlas Private Wealth Advisors
Matawan,
New Jersey
| – | -$39K | -12,000 | Closed |
|
|
TCWM
111
Total Clarity Wealth Management
St. Charles,
Illinois
| – | -$6K | -2,000 | Closed |
|
112
UBS Group
Zurich,
Switzerland
| – | -$6K | -1,942 | Closed |
|
|
PCIA
113
Prime Capital Investment Advisors
Overland Park,
Kansas
| – | -$1K | -275 | Closed |
|
INFI Hedge Fund Activity: Q2 2021 in Review
97 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Infinity Pharmaceuticals, Inc. (INFI) for Q2 2021, worth a combined $131M — down 3.7% from $136M a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new INFI positions and 18 closed out — a net gain of 14 holders — while 22 added to existing stakes and 24 trimmed.
The largest buyer was BlackRock, adding an estimated $12.8M. The largest seller was Consonance Capital Management, cutting an estimated $8.88M.
- 97 institutional investors held Infinity Pharmaceuticals, Inc. (INFI) as of Q2 2021, up from 83 in Q1 2021.
- Funds reported $131M of Infinity Pharmaceuticals, Inc. stock for Q2 2021, down 3.7% quarter-over-quarter.
- 32 funds opened new Infinity Pharmaceuticals, Inc. positions in Q2 2021 and 18 closed out, a net change of +14 holders.
- The largest Infinity Pharmaceuticals, Inc. buyer in Q2 2021 was BlackRock, an estimated $12.8M added.
- The largest Infinity Pharmaceuticals, Inc. seller in Q2 2021 was Consonance Capital Management, an estimated $8.88M sold.
Based on aggregated 13F filings for Q2 2021.